Attract talent




Poxel is a clinical-stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare disorders.


Add photos to showcase Poxel’s culture


Add Poxel’s values

Insider experiences

Share your experience of working at Poxel

Thomas Kuhn
CEO, Co-Founder
Anne Renevot
EVP, Chief Financial Officer
David E. Moller
EVP, Chief Scientific Officer
Quentin Durand
EVP, Chief Legal Officer
Sébastien Bolze
EVP, Chief Operating Officer, Co-Founder
Noah D. Beerman
EVP, Business Development & President, U.S. Operations
Pascale Fouqueray
EVP, Clinical Development & Regulatory Affairs, Co-Founder
Sophie Bozec
SVP, R&D Pharmacology & Scientific Communication, Co-Founder
Takashi Kaneko
SVP, Medical & President of Poxel Japan K.K.
Elizabeth Woo
SVP, Investor Relations, Public Relations & Corporate Communications
Sylvie Bertrand
VP, Human Resources

Add your teams to show how people work together at Poxel

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.